Clinical efficacy of levocarnitine supplementation in patients with hemodialysis

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: Levocarnitine injection 1000mg 3times weekly Control CONDITION: Hemodialysis patients PRIMARY OUTCOME: cardiac function, renal anemia, atherosclerosis INCLUSION CRITERIA: 1)Plasma free carnitine concentration less than 40 micro mol/L 2)duration of dialysis >12 months at enrollment 2)Patients who are treated with hemodialysis three times per week
Epistemonikos ID: 1d3fb2998906ac4400b30fd0d427a6cec26b149f
First added on: Aug 23, 2024